Nakajo-nishimura Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-12-21
Clinical Trial Update: A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS [Phase 2, Phase 3]
An update on a study of Baricitinib (LY3009104) in adult and pediatric Japanese participants with Nakajo-Nishimura Syndrome (NNS)/Chronic At…